1
|
Sap JBI, Meyer CF, Ford J, Straathof NJW, Dürr AB, Lelos MJ, Paisey SJ, Mollner TA, Hell SM, Trabanco AA, Genicot C, Am Ende CW, Paton RS, Tredwell M, Gouverneur V. [ 18F]Difluorocarbene for positron emission tomography. Nature 2022; 606:102-108. [PMID: 35344982 DOI: 10.1038/s41586-022-04669-2] [Citation(s) in RCA: 17] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Accepted: 03/21/2022] [Indexed: 11/09/2022]
Abstract
The advent of total-body positron emission tomography (PET) has vastly broadened the range of research and clinical applications of this powerful molecular imaging technology1. Such possibilities have accelerated progress in fluorine-18 (18F) radiochemistry with numerous methods available to 18F-label (hetero)arenes and alkanes2. However, access to 18F-difluoromethylated molecules in high molar activity is mostly an unsolved problem, despite the indispensability of the difluoromethyl group for pharmaceutical drug discovery3. Here we report a general solution by introducing carbene chemistry to the field of nuclear imaging with a [18F]difluorocarbene reagent capable of a myriad of 18F-difluoromethylation processes. In contrast to the tens of known difluorocarbene reagents, this 18F-reagent is carefully designed for facile accessibility, high molar activity and versatility. The issue of molar activity is solved using an assay examining the likelihood of isotopic dilution on variation of the electronics of the difluorocarbene precursor. Versatility is demonstrated with multiple [18F]difluorocarbene-based reactions including O-H, S-H and N-H insertions, and cross-couplings that harness the reactivity of ubiquitous functional groups such as (thio)phenols, N-heteroarenes and aryl boronic acids that are easy to install. The impact is illustrated with the labelling of highly complex and functionalized biologically relevant molecules and radiotracers.
Collapse
Affiliation(s)
- Jeroen B I Sap
- University of Oxford, Chemistry Research Laboratory, Oxford, UK
| | - Claudio F Meyer
- University of Oxford, Chemistry Research Laboratory, Oxford, UK
- Discovery Chemistry Janssen Research and Development, Toledo, Spain
| | - Joseph Ford
- University of Oxford, Chemistry Research Laboratory, Oxford, UK
| | | | | | | | - Stephen J Paisey
- Wales Research and Diagnostic PET Imaging Centre (PETIC), School of Medicine, Cardiff University, Cardiff, UK
| | - Tim A Mollner
- University of Oxford, Chemistry Research Laboratory, Oxford, UK
| | - Sandrine M Hell
- University of Oxford, Chemistry Research Laboratory, Oxford, UK
| | | | | | | | - Robert S Paton
- Department of Chemistry, Colorado State University, Fort Collins, CO, USA
| | - Matthew Tredwell
- Wales Research and Diagnostic PET Imaging Centre (PETIC), School of Medicine, Cardiff University, Cardiff, UK
- School of Chemistry, Cardiff University, Cardiff, UK
| | | |
Collapse
|
2
|
Mollner TA, Giltrap AM, Zeng Y, Demyanenko Y, Buchanan C, Oehlrich D, Baldwin AJ, Anthony DC, Mohammed S, Davis BG. Reductive site-selective atypical C, Z-type/N2-C2 cleavage allows C-terminal protein amidation. Sci Adv 2022; 8:eabl8675. [PMID: 35394836 PMCID: PMC8993120 DOI: 10.1126/sciadv.abl8675] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/16/2023]
Abstract
Biomolecule environments can enhance chemistries with the potential to mediate and modulate self-modification (e.g., self-cleavage). While these enhanced modes are found in certain biomolecules (e.g., RNA ribozymes), it is more rare in proteins. Targeted proteolytic cleavage is vital to physiology, biotechnology, and even emerging therapy. Yet, purely chemically induced methods for the site-selective cleavage of proteins remain scarce. Here, as a proof of principle, we designed and tested a system intended to combine protein-enhanced chemistry with tag modification to enable synthetic reductive protein chemistries promoted by diboron. This reductively driven, single-electron chemistry now enables an operationally simple, site-selective cleavage protocol for proteins directed to readily accessible dehydroalanine (Dha) residues as tags under aqueous conditions and in cell lysates. In this way, a mild, efficient, enzyme-free method now allows not only precise chemical proteolysis but also simultaneous use in the removal of affinity tags and/or protein-terminus editing to create altered N- and C-termini such as protein amidation (─CONH2).
Collapse
Affiliation(s)
- Tim A. Mollner
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
| | | | - Yibo Zeng
- The Rosalind Franklin Institute, Oxfordshire, UK
| | | | - Charles Buchanan
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
| | - Daniel Oehlrich
- Global Medicinal Chemistry, Janssen Research & Development, Beerse, Belgium
| | - Andrew J. Baldwin
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
- The Rosalind Franklin Institute, Oxfordshire, UK
| | | | - Shabaz Mohammed
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
- The Rosalind Franklin Institute, Oxfordshire, UK
- Department of Biochemistry, University of Oxford, Oxford, UK
| | - Benjamin G. Davis
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
- The Rosalind Franklin Institute, Oxfordshire, UK
- Department of Pharmacology, University of Oxford, Oxford, UK
- Corresponding author.
| |
Collapse
|
3
|
Mollner TA, Isenegger PG, Josephson B, Buchanan C, Lercher L, Oehlrich D, Hansen DF, Mohammed S, Baldwin AJ, Gouverneur V, Davis BG. Publisher Correction: Post-translational insertion of boron in proteins to probe and modulate function. Nat Chem Biol 2021; 18:116. [PMID: 34903852 PMCID: PMC8709785 DOI: 10.1038/s41589-021-00957-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022]
Affiliation(s)
- Tim A Mollner
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
| | - Patrick G Isenegger
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
| | - Brian Josephson
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
| | - Charles Buchanan
- Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford, UK
| | - Lukas Lercher
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
| | - Daniel Oehlrich
- Neuroscience Medicinal Chemistry, Janssen Research and Development, Beerse, Belgium
| | | | - Shabaz Mohammed
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK.,Department of Biochemistry, University of Oxford, Oxford, UK.,The Rosalind Franklin Institute, Oxfordshire, Oxford, UK
| | - Andrew J Baldwin
- Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford, UK.,The Rosalind Franklin Institute, Oxfordshire, Oxford, UK
| | - Véronique Gouverneur
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK
| | - Benjamin G Davis
- Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford, UK. .,The Rosalind Franklin Institute, Oxfordshire, Oxford, UK.
| |
Collapse
|